Fort LP’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-9,491
Closed -$581K 342
2020
Q1
$581K Sell
9,491
-1,270
-12% -$94.1K 0.13% 227
2019
Q4
$946K Buy
10,761
+1,089
+11% +$91.8K 0.17% 209
2019
Q3
$730K Buy
9,672
+3,212
+50% +$261K 0.14% 228
2019
Q2
$552K Sell
6,460
-12,698
-66% -$1.26M 0.11% 237
2019
Q1
$2.07M Sell
19,158
-62,936
-77% -$6.27M 0.42% 125
2018
Q4
$6.95M Sell
82,094
-23,701
-22% -$2.28M 1.64% 6
2018
Q3
$10.4M Sell
105,795
-53,258
-33% -$5.76M 2.32% 7
2018
Q2
$18.4M Sell
159,053
-19,206
-11% -$2.11M 4.35% 8
2018
Q1
$17.6M Buy
178,259
+5,848
+3% +$593K 4.23% 8
2017
Q4
$18.1M Buy
172,411
+8,885
+5% +$976K 4.25% 9
2017
Q3
$18.4M Sell
163,526
-15,479
-9% -$1.68M 4.53% 7
2017
Q2
$20.1M Buy
179,005
+3,748
+2% +$423K 5% 6
2017
Q1
$20.4M Buy
175,257
+17,673
+11% +$1.96M 5.4% 6
2016
Q4
$16.6M Buy
157,584
+8,570
+6% +$898K 4.67% 6
2016
Q3
$16.5M Buy
149,014
+29,942
+25% +$3.96M 5.67% 6
2016
Q2
$17.3M Buy
119,072
+29,743
+33% +$4.22M 7.08% 2
2016
Q1
$12.8M Buy
89,329
+25,654
+40% +$3.64M 5.4% 5
2015
Q4
$9.84M Buy
63,675
+31,911
+100% +$4.66M 4.69% 7
2015
Q3
$4.54M Buy
+31,764
New +$4.44M 2.34% 16

Other funds holding TARO

Fort LP's TARO Position: Q2 2020 in Review

Fort LP sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2020, closing a stake of 9,491 shares — an estimated $581K sold.

Fort LP first reported a position in TARO in Q3 2015 and held it in 19 quarters. The position peaked at $20.4M in Q1 2017. 84 funds tracked by Wall St. Rank hold TARO as of Q2 2020.

  • Fort LP reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2020 after selling out during the quarter.
  • Fort LP sold 9,491 Taro Pharmaceutical Industries Ltd. shares in Q2 2020, an estimated $581K.
  • Fort LP first reported a position in Taro Pharmaceutical Industries Ltd. in Q3 2015 and held it in 19 quarters.
  • Fort LP's Taro Pharmaceutical Industries Ltd. position peaked at $20.4M in Q1 2017.
  • 84 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2020.

Based on Fort LP's 13F filing for Q2 2020, filed 13 Aug 2020.